I'm LongbridgeAI, I can summarize articles.Ark Innovation ETF (ARKK) closed the week at $89.62, down 0.23%. The S&P 500 rose 1.15% over the same period, leaving ARKK about 1.38 percentage points behind the benchmark. Trading was front-loaded then faded: the fund opened Monday at $90.13, climbed to a high of $94.82 on Tuesday, then pulled back through Wednesday and Thursday to a low of $86.595 before rebounding on Friday. Weekly amplitude was 9.13%, and average daily volume of 5.02m shares ran about 11% above the median.
The Week
Ark Innovation ETF (ARKK) closed the week at $89.62, down 0.23%. The S&P 500 rose 1.15% over the same period, leaving ARKK about 1.38 percentage points behind the benchmark. Trading was front-loaded then faded: the fund opened Monday at $90.13, climbed to a high of $94.82 on Tuesday, then pulled back through Wednesday and Thursday to a low of $86.595 before rebounding on Friday. Weekly amplitude was 9.13%, and average daily volume of 5.02m shares ran about 11% above the median.
Sector News
Most of the week’s news flow centred on crypto-linked names and biotech. Robinhood said at its summit that it holds bitcoin, Coinbase became the default stablecoin custodian for Samsung Wallet, and Circle integrated USDC and EURC into SAP Cloud ERP payments. Meanwhile bitcoin slid to a two-week low, memecoin trading cooled, and Robinhood Chain transactions fell more than 40%. ARK funds doubled down on CoreWeave while selling $17m of Robinhood stock. In biotech, Tempus AI announced multi-year collaborations with Moderna and Merck to support commercialisation of the V940 melanoma vaccine, while Twist Bioscience fell amid CEO selling and ARK fund disposals. ARK ETF Trust filed N-CEN and N-CSR reports during the week.
The Week Ahead
The main event is US CPI and core CPI on Wednesday, 14 October. CPI last came in at 3.4, with the consensus at 3.7; core CPI was 2.4, forecast at 2.5. A meaningful deviation could shift rate expectations and feed into growth-stock valuations. On Tuesday, 13 October, NFIB small business optimism (prior 98.7) and existing home sales (prior 3.98m, forecast 3.96m) are also due. These prints will shape how risk assets are priced into the back half of the month.
In Short
ARKK slipped slightly while the S&P 500 rose, leaving the fund underperforming in a week when its price remained close to the top of its recent range. On the latest session, large-lot money was a net seller while small-lot money turned net buyer, a divergence worth watching. The fund closed at $89.62, above the 20-day average of $88.805 and the 60-day average of $82.959. With no PE or PB readings available, valuation does not add another pole to the story. Next week’s CPI and core CPI will test whether growth-style momentum can hold, while the large-lot versus small-lot flow split remains the key follow-through signal.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.